{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-077313","form_type":"8-K/A","ticker":"ARMP","cik":"0000921114","company_name":"Armata Pharmaceuticals, Inc.","filed_at":"2026-06-24T20:19:20+00:00","discovered_at":"2026-06-24T20:20:00.296457+00:00","generated_at":"2026-06-24T20:20:11.536762+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Armata Pharmaceuticals appoints Dr. Daniel Gilmer to Nominating and Corporate Governance Committee","bullets":["Dr. Daniel Gilmer appointed to the Nominating and Corporate Governance Committee effective June 24, 2026.","Committee cash retainer set at $5,000, pro-rated from effective date.","Amendment to April 24, 2026 8-K that reported his board appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-077313","json":"https://secwatch.observer/filing/0001104659-26-077313.json","markdown":"https://secwatch.observer/filing/0001104659-26-077313.md","text":"https://secwatch.observer/filing/0001104659-26-077313.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/921114/000110465926077313/0001104659-26-077313-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/921114/000110465926077313/tm2618503d2_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T20:20:11.536762+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}